产品封面图

MDA-MB-361

收藏
  • 询价
  • 2026年01月16日
    avatar
    15金牌会员
  • 企业认证

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 询价记录
    • 文献和实验
    • 技术资料
    • 物种来源

    • 是否是肿瘤细胞

      1

    • 细胞形态

      上皮样

    • 运输方式

      冻存运输

    • 器官来源

      乳房

    • 库存

      大量

    • 相关疾病

      腺癌

    • ATCC Number

      HTB-27™

    • 年限

      40 years

    • 生长状态

      贴壁生长

    Designations: MDA-MB-361
    Depositors:  R Cailleau
    Biosafety Level: 1
    Shipped: frozen
    Medium & Serum: See Propagation
    Growth Properties: loosely adherent
    Organism: Homo sapiens
    Morphology: epithelial

    Source: Organ: mammary gland; breast
    Disease: adenocarcinoma
    Derived from metastatic site: brain
    Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
    Oncogene: wnt7h +
    DNA Profile (STR): Amelogenin: X
    CSF1PO: 12
    D13S317: 11
    D16S539: 11,12
    D5S818: 10,11
    D7S820: 9,12
    THO1: 9.3
    TPOX: 8,11
    vWA: 17
    Cytogenetic Analysis: modal number. = 56; range = 54 to 61.
    The cell line is aneuploid human female, with chromosome counts in the hyperdiploid range. Normal chromosomes N11 and N17 are absent, chromosomes N1, N20, and N21 are weakly represented, and chromosomes N2, N8, N9, and N15 are single. The remainder of chromosomes are often paired. Eighteen marker chromosomes are found, of which 10 are consistently present. Some of these markers are found to be quite comparable to those described by K.L. Satya-Prakash, et al., in their report on this cell line.
    Isoenzymes: AK-1, 1
    ES-D, 1
    G6PD, B
    GLO-I, 2
    Me-2, 1
    PGM1, 1
    PGM3, 1-2
    Age: 40 years
    Gender: female
    Ethnicity: Caucasian
    Comments: This line differs from others of the series (ATCC HTB-23 to 26) in karyology and in that it was isolated from a brain metastasis.
    Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Leibovitz's L-15 Medium, Catalog No. 30-2008. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 20%.
    Temperature: 37.0°C
    Atmosphere: air, 100%
    Subculturing: Protocol:
    1. Remove and discard culture medium.
    2. Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum which contains trypsin inhibitor.
    3. Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
      Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37�C to facilitate dispersal.
    4. Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
    5. Add appropriate aliquots of the cell suspension to new culture vessels.
    6. Incubate cultures at 37�C.

    Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:6 is recommended
    Medium Renewal: 2 to 3 times per week
    Preservation: Freeze medium: Complete growth medium, 95%; DMSO, 5%
    Storage temperature: liquid nitrogen vapor phase
    Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2008
    recommended serum:ATCC 30-2020
    References: 1206: Brinkley BR, et al. Variations in cell form and cytoskeleton in human breast carcinoma cells in vitro. Cancer Res. 40: 3118-3129, 1980. PubMed: 7000337
    22182: Cruciger Q, et al. Morphological, biochemical and chromosomal characterization of breast tumor lines from pleural effusions. In Vitro 12: 331, 1976.
    22429: Siciliano MJ, et al. Mutually exclusive genetic signatures of human breast tumor cell lines with a common chromosomal marker. Cancer Res. 39: 919-922, 1979. PubMed: 427779
    22532: Cailleau R, et al. Breast tumor cell lines from pleural effusions. J. Natl. Cancer Inst. 53: 661-674, 1974. PubMed: 4412247
    22536: Fogh J, et al. Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J. Natl. Cancer Inst. 58: 209-214, 1977. PubMed: 833871
    22656: Cailleau R, et al. Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 14: 911-915, 1978. PubMed: 730202
    23093: Faust JB, Meeker TC. Amplification and expression of the bcl-1 gene in human solid tumor cell lines. Cancer Res. 52: 2460-2463, 1992. PubMed: 1568216
    23113: Huguet EL, et al. Differential expression of human Wnt genes 2, 3, 4, and 7B in human breast cell lines and normal and disease states of human breast tissue. Cancer Res. 54: 2615-2621, 1994. PubMed: 8168088

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    • 作者
    • 内容
    • 询问日期
    图标文献和实验
    相关实验
    • Bcap-37和MDA-MB-435细胞的传代

      Bcap-37和MDA-MB-435细胞都是人乳腺癌细胞,培养液用DMEM或1640均可,小牛血清10%就足够,不过感觉435细胞用DMEM长得更旺一些。两种细胞都很好养,Bcap-37可称为是最漂亮的乳腺癌细胞,一个个成排列均匀的瓜子状,形态规则,长得也快,一般1:2传代后2-3天即可长满。435长的较慢,需4-5天。传代常规用0.25%的胰酶消化后用含血清的培养基终止消化,视消化程度而决定是否需要离心,传入新瓶加入培养液即可。需要注意的是传代时的密度,特别是435密度低时很难生长。一般生长

    • 人乳腺癌的裸鼠移植模型的制作

      HBC裸鼠移植模型的建立包括活检取材的HBC标本和细胞株,后者应用较广泛。本贴主要讨论后者,算是抛砖了!1、人乳腺癌细胞株的选择目前人乳腺癌细胞建株的癌细胞较多,本人曾接触过细胞株总结如下:ER(+):MCF-7(来源:乳腺腺癌),ZR-75-30(乳腺导管癌),T47D(乳腺导管癌),ZR-75(乳腺腺癌)。ER(-):MDA-MB-435s(乳腺导管癌),MDA-MB-435(乳腺导管癌),SK-BR-3 (乳腺腺癌),MDA-MB-231(乳腺腺癌),MDA-MB-453(乳腺

    • 警惕!这种常见的维生素片,或增加癌症发生和转移风险

      的新陈代谢来补充这种能量,因此 Goun 想要研究 NR 在癌症发展和扩散中的作用。 通过使用 BiNR 探针,研究人员对四种人乳腺癌细胞系(MDA-MB-231-luc、MDA-MB-468-luc、MCF-7-luc 和 BT-20-luc)的烟酰胺核糖摄取进行了量化,并发现一种高侵略性的三阴乳腺癌细胞系对于烟酰胺核糖的摄取率最高。 接下来,他们 MDA-MB-231 异种移植肿瘤利用小鼠模型,探索烟酰胺核糖是否会增加癌症发病和转移。令人惊讶的是,研究结果显示,烟酰胺核糖的补充会导致小鼠

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1800
    博辉生物科技(广州)有限公司
    2025年10月28日询价
    ¥1980
    上海酶研生物科技有限公司
    2025年07月25日询价
    ¥1280
    上海康朗生物科技有限公司
    2026年01月23日询价
    询价
    上海复祥生物科技有限公司
    2025年08月06日询价
    ¥2200
    上海钰博生物科技有限公司
    2024年04月07日询价
    MDA-MB-361
    询价